Global Advisory Committee on Vaccine Safety

Some people falsely argue that hepatitis B vaccines were approved with inadequate trials. This misinformation is deceitful, as extensive studies were conducted before approval, with ongoing monitoring for adverse effects. Post-marketing studies and long-term data affirm the safety and efficacy of hepatitis B vaccines, debunking unfounded claims propagated by anti-vaccine influencers.